Crystallographic and kinetic evidence of allostery in a trypsin-like protease.

Protein allostery is based on the existence of multiple conformations in equilibrium linked to distinct functional properties. Although evidence of allosteric transitions is relatively easy to identify by functional studies, structural detection of a pre-existing equilibrium between alternative conformations remains challenging even for textbook examples of allosteric proteins. Kinetic studies show that the trypsin-like protease thrombin exists in equilibrium between two conformations where the active site is either collapsed (E*) or accessible to substrate (E). However, structural demonstration that the two conformations exist in the same enzyme construct free of ligands has remained elusive. Here we report the crystal structure of the thrombin mutant N143P in the E form, which complements the recently reported structure in the E* form, and both the E and E* forms of the thrombin mutant Y225P. The side chain of W215 moves 10.9 Å between the two forms, causing a displacement of 6.6 Å of the entire 215-217 segment into the active site that in turn opens or closes access to the primary specificity pocket. Rapid kinetic measurements of p-aminobenzamidine binding to the active site confirm the existence of the E*-E equilibrium in solution for wild-type and the mutants N143P and Y225P. These findings provide unequivocal proof of the allosteric nature of thrombin and lend strong support to the recent proposal that the E*-E equilibrium is a key property of the trypsin fold.

[1]  M. Page,et al.  Serine peptidases: Classification, structure and function , 2008, Cellular and Molecular Life Sciences.

[2]  E. Di Cera,et al.  Stabilization of the E* Form Turns Thrombin into an Anticoagulant* , 2009, The Journal of Biological Chemistry.

[3]  P. Gros,et al.  Structure of complement component C2A: implications for convertase formation and substrate binding. , 2006, Structure.

[4]  W. Grabarse,et al.  Monomeric structures of the zymogen and active catalytic domain of complement protease c1r: further insights into the c1 activation mechanism. , 2002, Structure.

[5]  H. Su,et al.  Structure of Human Prostasin, a Target for the Regulation of Hypertension* , 2008, Journal of Biological Chemistry.

[6]  Andrea Schmidt,et al.  On the routine use of soft X-rays in macromolecular crystallography. Part IV. Efficient determination of anomalous substructures in biomacromolecules using longer X-ray wavelengths. , 2007, Acta crystallographica. Section D, Biological crystallography.

[7]  G. Murshudov,et al.  Refinement of macromolecular structures by the maximum-likelihood method. , 1997, Acta crystallographica. Section D, Biological crystallography.

[8]  M. Krem,et al.  Evolution of enzyme cascades from embryonic development to blood coagulation. , 2002, Trends in biochemical sciences.

[9]  S. Narayana,et al.  Structural analysis of engineered Bb fragment of complement factor B: insights into the activation mechanism of the alternative pathway C3-convertase. , 2004, Molecular cell.

[10]  E. Di Cera,et al.  Mutant N143P Reveals How Na+ Activates Thrombin* , 2009, The Journal of Biological Chemistry.

[11]  M. Krem,et al.  Molecular markers of serine protease evolution , 2001, The EMBO journal.

[12]  E. Cera,et al.  Rational engineering of activity and specificity in a serine protease , 1997, Nature Biotechnology.

[13]  Aaron Shipway,et al.  Active site conformational changes of prostasin provide a new mechanism of protease regulation by divalent cations , 2009, Protein science : a publication of the Protein Society.

[14]  L. DeLucas,et al.  Structural basis of profactor D activation: from a highly flexible zymogen to a novel self‐inhibited serine protease, complement factor D , 1999, The EMBO journal.

[15]  S. Prasad,et al.  Molecular Dissection of Na+ Binding to Thrombin* , 2004, Journal of Biological Chemistry.

[16]  E. Di Cera,et al.  Important Role of the Cys-191–Cys-220 Disulfide Bond in Thrombin Function and Allostery* , 2007, Journal of Biological Chemistry.

[17]  Christine Gaboriaud,et al.  Deciphering complement mechanisms: the contributions of structural biology. , 2007, Molecular immunology.

[18]  M. James,et al.  Rat submaxillary gland serine protease, tonin. Structure solution and refinement at 1.8 A resolution. , 1987, Journal of molecular biology.

[19]  F. S. Mathews,et al.  Structural identification of the pathway of long-range communication in an allosteric enzyme , 2008, Proceedings of the National Academy of Sciences.

[20]  E. Di Cera,et al.  Evidence of the E*-E equilibrium from rapid kinetics of Na+ binding to activated protein C and factor Xa. , 2010, The journal of physical chemistry. B.

[21]  F. Scott Mathews,et al.  Crystal Structure of Thrombin in a Self-inhibited Conformation* , 2006, Journal of Biological Chemistry.

[22]  Z. Otwinowski,et al.  [20] Processing of X-ray diffraction data collected in oscillation mode. , 1997, Methods in enzymology.

[23]  P. S. Gandhi,et al.  Na+ binding to meizothrombin desF1 , 2008, Cellular and Molecular Life Sciences.

[24]  J. Changeux,et al.  ON THE NATURE OF ALLOSTERIC TRANSITIONS: A PLAUSIBLE MODEL. , 1965, Journal of molecular biology.

[25]  S. Savvides,et al.  Crystal Structure of the Anticoagulant Slow Form of Thrombin* , 2002, The Journal of Biological Chemistry.

[26]  Nam-Chul Ha,et al.  Crystal structure of a clip‐domain serine protease and functional roles of the clip domains , 2005, The EMBO journal.

[27]  L. DeLucas,et al.  Structure of human factor D. A complement system protein at 2.0 A resolution. , 1994, Journal of molecular biology.

[28]  L. Hedstrom Serine protease mechanism and specificity. , 2002, Chemical reviews.

[29]  David W. Banner,et al.  The crystal structure of the complex of blood coagulation factor VIIa with soluble tissue factor , 1996, Nature.

[30]  Kevin Cowtan,et al.  research papers Acta Crystallographica Section D Biological , 2005 .

[31]  M. Ultsch,et al.  The factor VII zymogen structure reveals reregistration of beta strands during activation. , 2001, Structure.

[32]  E. Di Cera,et al.  Allostery in trypsin-like proteases suggests new therapeutic strategies. , 2011, Trends in biotechnology.

[33]  Piet Gros,et al.  Complement driven by conformational changes , 2008, Nature Reviews Immunology.

[34]  M. Morales,et al.  Analytical description of the effects of modifiers and of enzyme multivalency upon the steady state catalyzed reaction rate , 1953 .

[35]  Patrice Vachette,et al.  Direct observation in solution of a preexisting structural equilibrium for a mutant of the allosteric aspartate transcarbamoylase , 2007, Proceedings of the National Academy of Sciences.

[36]  W. Ruf,et al.  Identification of surface residues mediating tissue factor binding and catalytic function of the serine protease factor VIIa. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[37]  D. Kirchhofer,et al.  Conformational lability in serine protease active sites: structures of hepatocyte growth factor activator (HGFA) alone and with the inhibitory domain from HGFA inhibitor-1B. , 2005, Journal of molecular biology.

[38]  Z. Otwinowski,et al.  Processing of X-ray diffraction data collected in oscillation mode. , 1997, Methods in enzymology.

[39]  K. Matsumoto,et al.  Crystal Structure of Neuropsin, a Hippocampal Protease Involved in Kindling Epileptogenesis* , 1999, The Journal of Biological Chemistry.

[40]  Max F. Perutz,et al.  Mechanisms of Cooperativity and Allosteric Regulation in Proteins , 1990 .

[41]  R. Huber,et al.  The crystal structure of human alpha1-tryptase reveals a blocked substrate-binding region. , 2002, Journal of molecular biology.

[42]  Carl Frieden Kinetic aspects of regulation of metabolic processes. The hysteretic enzyme concept. , 1970, The Journal of biological chemistry.

[43]  J. Thornton,et al.  Stereochemical quality of protein structure coordinates , 1992, Proteins.

[44]  Jin Wu,et al.  Structures of C3b in Complex with Factors B and D Give Insight into Complement Convertase Formation , 2010, Science.

[45]  C. Craik,et al.  Structural basis of substrate specificity in the serine proteases , 1995, Protein science : a publication of the Protein Society.

[46]  E. Di Cera,et al.  Engineering Thrombin for Selective Specificity toward Protein C and PAR1* , 2010, The Journal of Biological Chemistry.

[47]  E. Cera A Structural Perspective on Enzymes Activated by Monovalent Cations , 2006 .

[48]  Collaborative Computational,et al.  The CCP4 suite: programs for protein crystallography. , 1994, Acta crystallographica. Section D, Biological crystallography.

[49]  R. Huber,et al.  X-ray Structures of Free and Leupeptin-complexed Human αI-Tryptase Mutants: Indication for an α→β-Tryptase Transition , 2006 .

[50]  S. Evans,et al.  p-Aminobenzamidine as a fluorescent probe for the active site of serine proteases. , 1982, The Journal of biological chemistry.

[51]  Juan J Calvete,et al.  Crystal structure of a prostate kallikrein isolated from stallion seminal plasma: a homologue of human PSA. , 2002, Journal of molecular biology.

[52]  E. Di Cera A Structural Perspective on Enzymes Activated by Monovalent Cations* , 2006, Journal of Biological Chemistry.

[53]  E. Di Cera,et al.  Rapid Kinetics of Na+ Binding to Thrombin* , 2006, Journal of Biological Chemistry.

[54]  G Waksman,et al.  Unexpected crucial role of residue 225 in serine proteases. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[55]  S. Narayana,et al.  The crystal structure of C2a, the catalytic fragment of classical pathway C3 and C5 convertase of human complement. , 2007, Journal of molecular biology.

[56]  E. Di Cera,et al.  Residue 225 determines the Na(+)-induced allosteric regulation of catalytic activity in serine proteases. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[57]  S. Narayana,et al.  Structures of native and complexed complement factor D: implications of the atypical His57 conformation and self-inhibitory loop in the regulation of specific serine protease activity. , 1998, Journal of molecular biology.